Companies / Stryker

Stryker coverage

16 issues

• AOFAS Vancouver Preview: Sneak Peeks from the Exhibit Hall

  Product releases before they hit the floor, plus a new social platform for surgeons.

• The Artelon Playbook: How to Engineer an Exit

  Stryker pulls the trigger. Here is the five-step playbook that got Artelon there.

• Treace and Paragon 28 by the Numbers, Plus Lapidus Launches

  FY2023 results for the two public pure-plays, and a newcomer in biologics.

• Year-End Launches: DJO Nitinol, a Treace Plate, and Stryker Anchors

  Q4 is usually about hitting numbers. This one brought real products instead.

• A New 3D PSI Player Enters the Rotational Lapidus Race

  A new product, an AR acquisition, and patient-specific instrumentation for Lapidus.

• Six New Product Launches, Plus Ex-Fix Specialists Worth Knowing

  Four companies, six products, and new total ankle literature worth your time.

• The Syndesmosis Market, Reviewed

  The soft tissue battle heats up as Paragon 28 and Medline UNITE debut new products.

• Fusion Orthopedics Challenges Treace in the Lapidus Fight

  A rotational Lapidus jig, a radiolucent frame, and a wireless scope walk into a quarter.

• The CMS Amniotic Clawback Is Coming

  Medicare wants its money back, plus a new surgeon CMO and a run of fresh launches.

• ACFAS in Austin: Product Launches and Little Guys

  FAN worked the floor in Austin. Here is what was actually worth stopping for.

• Golden Demobone Awards: Treace Takes Rotational Bunion, Plus a Market Share Read

  A winner in the year's most contested category, plus where market share is heading.

• Golden Demobone Awards: Rotational Bunion and MIS Products of the Year

  The two hottest markets in foot and ankle go head to head for hardware of the year.

• Golden Demobone Awards: Acquisition of the Year

  The votes are in on the year's biggest deal, and two new categories open.

• Introducing the Golden Demobone Awards

  FAN's first annual awards for the products, people, and deals that defined the year.

• The Nitinol Wars: CrossRoads, MedShape, and Arthrex Escalate

  Everyone has a nitinol staple. These three are trying to do more with it.

• Total Ankle Shake-Up: The STAR Lands at DJO

  Regulators force a divestiture, Vilex takes Hintegra, and APEX 3D clears the FDA.